Heparin for patients with coronavirus disease 2019 and hypercoagulation complications: A cohort study

BACKGROUND: Thrombotic complications of coronavirus disease 2019 (COVID-19) are a worrisome aspect of the disease due to their high incidence in critically ill patients and their poor clinical outcomes. The aim of this study was to compare the effectiveness of unfractionated heparin (UFH) and low mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fachri, Muhammad, Hatta, Mochammad, Tarigan, Sefia Nabila Nur Azmi, Akaputra, Risky, Dwiyanti, Ressy, Syukri, Ahmad, Junita, Ade Rifka, Primaguna, Muhammad Reza, Febrianty, Andini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238275/
https://www.ncbi.nlm.nih.gov/pubmed/35784948
http://dx.doi.org/10.1016/j.amsu.2022.104042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238275/
https://www.ncbi.nlm.nih.gov/pubmed/35784948
http://dx.doi.org/10.1016/j.amsu.2022.104042

Ejemplares similares